NEXI - Why Is NexImmune (NEXI) Stock Down 4% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
NexImmune (NASDAQ:NEXI) stock is falling on Friday as the immunotherapies company’s shares come off of a recent high earlier this week.
The NEXI stock rally started earlier this week and has seen the company’s shares go through several rises and falls. That’s not too surprising as the company’s stock is firmly in penny territory. That means it’s more likely o experience volatility and traders buy and sell shares.
While the company’s stock is falling today, it doesn’t appear to be due to any negative news. The latest press release covers its publication in Frontiers in Medicine, which happened earlier this week. At the time, the company’s shares got a boost from the news.
Instead, it seems likely that the drop in price today comes from the stock retreating from that recent rally. That makes sense as the price of NEXI stock has been dipping back down to levels from before its publication announcement.
What Else Is Happening With NEXI Stock
The decreasing price of NEXI stock also comes as it sees little in the way of trading. That was true yesterday when it failed to reach its daily average trading volume of about 261,000 shares. It looks like the company is seeing the same disinterest today as less than 1,000 shares of the stock have traded as of this writing.
NEXI stock is down 3.6% as of Friday morning.
Investors seeking more of the latest stock market news today are in luck!
InvestorPlace is home to all of the latest stock market news for Friday! Our coverage includes what’s happening with shares of Tempo Automation (NASDAQ:TMPO), Genius (NASDAQ:GNUS), and WiSA Technologies (NASDAQ:WISA) stock today. You can learn all about that at the following links!
More Friday Stock Market News
- Why Is Tempo Automation (TMPO) Stock Down 17% Today?
- Why Is Genius (GNUS) Stock Up 4% Today?
- Why Is WiSA Technologies (WISA) Stock Up 37% Today?
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that? InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More:?Penny Stocks — How to Profit Without Getting Scammed
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- It doesn’t matter if you have $500 or $5 million. Do this now.
- Early Bitcoin Millionaire Reveals His Next Big Crypto Trade “On Air”
The post Why Is NexImmune (NEXI) Stock Down 4% Today? appeared first on InvestorPlace.